北京大学学报(医学版) ›› 2019, Vol. 51 ›› Issue (6): 985-988. doi: 10.19723/j.issn.1671-167X.2019.06.001
• 专家笔谈 • 下一篇
中图分类号:
[1] | He J, Zhang R, Shao M , et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial[J/OL]. Ann Rheum Dis, 2019, 9(2019-09-19)[2019-10-01]. . |
[2] | He J, Zhang X, Wei Y , et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus[J]. Nat Med, 2016,22(9):991-993. |
[3] | Rosenzwajg M, Lorenzon R, Cacoub P , et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial[J]. Ann Rheum Dis, 2019,78(2):209-217. |
[4] | Morgan DA, Ruscetti FW, Gallo R . Selective in vitro growth of T lymphocytes from normal human bone marrows[J]. Science, 1976,193(4257):1007-1008. |
[5] | Mizel SB, Farrar JJ . Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors[J]. Cell Immunol, 1979,48(2):433-436. |
[6] | Shao Q, Gao H,. Progress in interleukin-2 therapy for rheumatic immune diseases by regulating the immune balance of T cells[J/OL]. Scand J Immunol, 2019, 9(2019-09-08)[2019-10-01]. |
[7] | Sakaguchi S, Wing K, Miyara M . Regulatory T cells: A brief history and perspective[J]. Eur J Immunol, 2007,37(Suppl 1):116-123. |
[8] | Harrington LE, Hatton RD, Mangan PR , et al. Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J]. Nat Immunol, 2005,6(11):1123-1132. |
[9] | Zhao Z, Zhang X, Su L , et al. Fine tuning subsets of CD4+T cells by low-dosage of IL-2 and a new therapeutic strategy for autoimmune diseases [J]. Int Immunopharmacol, 2018,56:269-276. |
[10] | Kim HS, Jang SW, Lee W , et al. PTEN drives Th17 cell differentiation by preventing IL-2 production[J]. J Exp Med, 2017,214(11):3381-3398. |
[11] | Osnes LT, Nakken B, Bodolay E , et al. Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and pri-mary immunodeficiencies: Novel tool for diagnostics and patient follow-up[J]. Autoimmun Rev, 2013,12(10):967-971. |
[12] | Li J, Lu E, Yi T , et al. EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells[J]. Nature, 2016,533(7601):110-114. |
[13] | Shao M, He J, Zhang R , et al. Interleukin-2 deficiency associated with renal impairment in systemic lupus erythematosus[J]. J Interferon Cytokine Res, 2019,39(2):117-124. |
[14] | Shin MS, Lee N, Kang I . Effector T-cell subsets in systemic lupus erythematosus: Update focusing on Th17 cells[J]. Curr Opin Rheumatol, 2011,23(5):444-448. |
[15] | Betts BC, Pidala J, Kim J , et al. IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation[J]. Haematologica, 2017,102(5):948-957. |
[16] | Zhao XY, Zhao XS, Wang YT , et al. Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study[J]. Oncoimmunology, 2016,5(12):e1250992. |
[17] | Saadoun D, Rosenzwajg M, Joly F , et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis[J]. N Engl J Med, 2011,365(22):2067-2077. |
[18] | Hartemann A, Bensimon G, Payan CA , et al. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial[J]. Lancet Diabetes Endocrinol, 2013,1(4):295-305. |
[19] | Zhang J, Ruan Y, Shen Y , et al. Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia[J]. Cytometry B Clin Cytom, 2018,94(3):400-404. |
[20] | Zhang J, Ruan Y, Xu X , et al. Therapeutic potential of low-dose IL-2 in immune thrombocytopenia: An analysis of 3 cases[J]. Cytom B Clin Cytom, 2018,94(3):428-433. |
[21] | Castela E, Le Duff F, Butori C , et al. Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata[J]. JAMA Dermatol, 2014,150(7):748-751. |
[22] | Miao M, Hao Z, Guo Y , et al. Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with pri-mary Sjögren’s syndrome[J]. Ann Rheum Dis, 2018,77(12):1838-1840. |
[23] | Zhang S, Wang J, Sun H , et al. Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2[J/OL]. Ann Rheum Dis, 2019, 10(2019-10-14)[2019-10-16]. |
[24] | An H, Li X, Li F , et al. The absolute counts of peripheral T lymphocyte subsets in patient with ankylosing spondylitis and the effect of low-dose interleukin-2[J]. Medicine (Baltimore), 2019,98(15):e15094. |
[1] | 田佳宜,张霞,程功,刘庆红,王世阳,何菁. 系统性红斑狼疮患者血清白细胞介素-2受体α水平及其临床意义[J]. 北京大学学报(医学版), 2021, 53(6): 1083-1087. |
[2] | 张朴丽,杨红霞,张立宁,葛勇鹏,彭清林,王国春,卢昕. 血清YKL-40在诊断抗黑色素瘤分化相关基因5阳性皮肌炎合并严重肺损伤中的价值[J]. 北京大学学报(医学版), 2021, 53(6): 1055-1060. |
[3] | 孟洪,季丽娜,黄静,晁爽,周佳雯,李学军,尹小梅,樊丽容. COVID-19疫情前后北京市某综合医院儿科门诊患儿就诊量变化分析[J]. 北京大学学报(医学版), 2021, 53(5): 952-956. |
[4] | 王成,孟令宇,陈拿云,李玳,王健全,敖英芳. 前交叉韧带重建术后膝关节感染的诊断和治疗策略[J]. 北京大学学报(医学版), 2021, 53(5): 850-856. |
[5] | 杜强,洪锴,潘伯臣. 两种检测男性生殖道沙眼衣原体和解脲支原体方法的对比[J]. 北京大学学报(医学版), 2021, 53(4): 785-788. |
[6] | 周柏林,李危石,孙垂国,齐强,陈仲强,曾岩. 脊柱手术后深部切口感染患者多次清创的危险因素[J]. 北京大学学报(医学版), 2021, 53(2): 286-292. |
[7] | 袁源,郎宁,袁慧书. CT能谱曲线在脊柱转移瘤和感染性病变中的鉴别诊断价值[J]. 北京大学学报(医学版), 2021, 53(1): 183-187. |
[8] | 包芳,史尉利,胡静,张娣,高东晗,夏云霞,景红梅,克晓燕,葛庆岗,沈宁. 新型冠状病毒肺炎淋巴细胞亚群与严重程度的相关分析[J]. 北京大学学报(医学版), 2020, 52(6): 1075-1081. |
[9] | 袁晓宁,孟庆阳,沈宁,李宇轩,梁超,崔曼,葛庆岗,李晓光,谭昆,陈茜,王晶,曾晓勇. 新型冠状病毒肺炎病区环境及医务人员防护设备表面SARS-CoV-2核酸污染的检测与评价[J]. 北京大学学报(医学版), 2020, 52(5): 803-808. |
[10] | 王秋,郭金玉,孙红,王泠,应菊素,刘慧鑫. 抗击新型冠状病毒肺炎一线护理人员防护暴露风险事件调查[J]. 北京大学学报(医学版), 2020, 52(4): 711-714. |
[11] | 邢燕,张娟,韩彤妍,李在玲,李蕊,童笑梅. 新型冠状病毒感染肺炎疫情下综合医院儿科防控方式探索[J]. 北京大学学报(医学版), 2020, 52(3): 410-413. |
[12] | 陈美恋,高燕,郭维,左力,王天兵. 新型冠状病毒肺炎患者床旁血液净化治疗的感染防控[J]. 北京大学学报(医学版), 2020, 52(3): 414-419. |
[13] | 段姣妞,杜伟,侯睿宏,许珂,张改连,张莉芸. 类脂质渐进性坏死1例[J]. 北京大学学报(医学版), 2019, 51(6): 1182-1184. |
[14] | 张思,刘小扬,张建中,蔡林,周城. 继发呼吸道烟曲霉菌感染的中毒性表皮坏死松解型药疹1例[J]. 北京大学学报(医学版), 2019, 51(5): 977-980. |
[15] | 杨阳,刘毅强,王晓红,季科,李忠武,白健,杨爱蓉,胡颖,韩海勃,李子禹,步召德,吴晓江,张连海,季加孚. 单中心大样本Epstein-Barr病毒相关性胃癌亚型的临床病理及分子特征分析[J]. 北京大学学报(医学版), 2019, 51(3): 451-458. |
|